Stockreport

Xilio Therapeutics Announces Pricing of Underwritten Offering

Xilio Therapeutics, Inc.  (XLO) 
PDF WALTHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immu [Read more]